87 related articles for article (PubMed ID: 3297957)
1. [Treatment of drug-induced gastrointestinal disorders. Double-blind study of the effectiveness of Iberogast compared to placebo].
Mac Lean N; Hübner-Steiner U
Fortschr Med; 1987 Apr; 105(12):239-42. PubMed ID: 3297957
[No Abstract] [Full Text] [Related]
2. [The association of lexotan + propantheline in the treatment of functional gastrointestinal disorders. Controlled clinical study].
Riva D; Manieri L; Mariano P
Arch Sci Med (Torino); 1980; 137(3):461-6. PubMed ID: 6112973
[No Abstract] [Full Text] [Related]
3. [Double-blind double-controlled polycenter study on the therapeutic activity of a well-known combination of medicinal herbs].
Borgia M; Camarri E; Cataldi V; Frigerio G; Minerva V; Miracco A
Clin Ter; 1985 Sep; 114(5):401-9. PubMed ID: 3902340
[No Abstract] [Full Text] [Related]
4. [Gastrointestinal diseases. Therapy with Iberogast].
Bremer W; Fischer F; Nicolay K
ZFA (Stuttgart); 1983 Oct; 59(30):1706-9. PubMed ID: 6659661
[No Abstract] [Full Text] [Related]
5. [Asa foetida in the treatment of the irritable colon: a double-blind trial (author's transl)].
Rahlfs VW; Mössinger P
Dtsch Med Wochenschr; 1979 Jan; 104(4):140-3. PubMed ID: 365493
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and therapy of peptic ulcer. Clinical report with double-blind study].
Bouzo H
Med Welt; 1979 Jun; 30(25):979-84. PubMed ID: 379497
[No Abstract] [Full Text] [Related]
7. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C
Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133
[TBL] [Abstract][Full Text] [Related]
8. Fenoverine: a two-step, double-blind and open clinical assessments of its smooth muscle synchronizing effects.
Bader F
Pharmatherapeutica; 1986; 4(7):422-8. PubMed ID: 3515369
[TBL] [Abstract][Full Text] [Related]
9. [Double blind comparative study of Trilifan and Mutanxion in the treatment of functional digestive disorders].
Truchot R
Therapeutique; 1971 Mar; 47(3):261-3. PubMed ID: 4934009
[No Abstract] [Full Text] [Related]
10. [Flupentixol (Fluanxol) or diazepam in the treatment of various psychosomatic conditions. A controlled double-blind multicenter study].
Damsbo N; Lassen T; Falhof SL
Ugeskr Laeger; 1986 Dec; 149(1):12-6. PubMed ID: 3544417
[No Abstract] [Full Text] [Related]
11. A double-blind study of effectiveness of hericium erinaceus pers therapy on chronic atrophic gastritis. A preliminary report.
Xu CP; Liu WW; Liu FX; Chen SS; Liao FQ; Xu Z; Jiang LG; Wang CA; Lu XH
Chin Med J (Engl); 1985 Jun; 98(6):455-6. PubMed ID: 3932005
[No Abstract] [Full Text] [Related]
12. [The efficacy of a combination herbal medicine in the treatment of functional dyspepsia. Meta-analysis of randomized double-blind studies on the basis of a valid gastrointestinal symptom profile].
Gundermann KJ; Godehardt E; Ulbrich M
MMW Fortschr Med; 2004 Aug; 146 Suppl 2():71-6. PubMed ID: 16739362
[TBL] [Abstract][Full Text] [Related]
13. [Iberogast: a modern phytotherapeutic combined herbal drug for the treatment of functional disorders of the gastrointestinal tract (dyspepsia, irritable bowel syndrome)--from phytomedicine to "evidence based phytotherapy." A systematic review].
Saller R; Pfister-Hotz G; Iten F; Melzer J; Reichling J
Forsch Komplementarmed Klass Naturheilkd; 2002 Dec; 9 Suppl 1():1-20. PubMed ID: 12618546
[TBL] [Abstract][Full Text] [Related]
14. Low-dose haloperidol as antiemetic treatment in gastrointestinal disorders: a double-blind study.
Christman RS; Weinstein RA; Larose JB
Curr Ther Res Clin Exp; 1974 Nov; 16(11):1171-6. PubMed ID: 4214651
[No Abstract] [Full Text] [Related]
15. Double-blind trial comparing the effectiveness of the homeopathic preparation Galphimia potentiation D6, Galphimia dilution 10(-6) and placebo on pollinosis.
Wiesenauer M; Gaus W
Arzneimittelforschung; 1985; 35(11):1745-7. PubMed ID: 3911965
[TBL] [Abstract][Full Text] [Related]
16. [Clinical experiences with the amphocholereticum Oddibil].
Zawodsky L
Wien Med Wochenschr; 1974 Nov; 124(46):677-80. PubMed ID: 4617977
[No Abstract] [Full Text] [Related]
17. [New treatment possibilities in gastrointestinal diseases: bromoprid].
Krapf W
Med Klin; 1980 Oct; 75(22):790-1. PubMed ID: 7005632
[No Abstract] [Full Text] [Related]
18. [DA 3177 a new synthetic spasmolytic agent in the management of spastic-dyskinetic conditions of the digestive tract. Double-blind controlled clinical trial].
Bonzi G; Reguzzoni G; Rocca F; Negri L
Clin Ter; 1979 Apr; 89(2):187-96. PubMed ID: 385213
[No Abstract] [Full Text] [Related]
19. Peppermint oil does not relieve the pain of irritable bowel syndrome.
Nash P; Gould SR; Bernardo DE
Br J Clin Pract; 1986 Jul; 40(7):292-3. PubMed ID: 3527248
[No Abstract] [Full Text] [Related]
20. [The effectiveness of a Ginkgobiloba preparation in arterial ischemic diseases of the leg. Controlled double-blind cross-over study].
Salz H
Ther Ggw; 1980 Nov; 119(11):1345-56. PubMed ID: 7466686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
